Rapt Therapeutics
Biotechnology, 561 Eccles Ave, South San Francisco, California, 94080, United States, 51-200 Employees
Phone Number: 65********
Who is RAPT THERAPEUTICS
RAPT Therapeutics is a clinical stage immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with signific...
Read More
-
Headquarters: 561 Eccles Ave, South San Francisco, California, 94080, United States
-
Date Founded: 2015
-
Employees: 51-200
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 541511 |
Show More
Does something look wrong? Fix it. | View contact records from RAPT THERAPEUTICS
RAPT Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding RAPT Therapeutics
Answer: RAPT Therapeutics's headquarters are located at 561 Eccles Ave, South San Francisco, California, 94080, United States
Answer: RAPT Therapeutics's phone number is 65********
Answer: RAPT Therapeutics's official website is https://rapt.com
Answer: RAPT Therapeutics's revenue is $1 Million to $5 Million
Answer: RAPT Therapeutics's SIC: 2834
Answer: RAPT Therapeutics's NAICS: 541511
Answer: RAPT Therapeutics has 51-200 employees
Answer: RAPT Therapeutics is in Biotechnology
Answer: RAPT Therapeutics contact info: Phone number: 65******** Website: https://rapt.com
Answer: RAPT Therapeutics is a clinical stage immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, RPT193 and FLX475, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The company is also pursuing a range of targets that are in the discovery stage of development.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month